(1E,4E)-1-(1-(sec-Butyl)-1H-imidazol-2-yl)-5-(5-methylisoxazol-3-yl)penta-1,4-dien-3-one

ID: ALA4211719

PubChem CID: 145964798

Max Phase: Preclinical

Molecular Formula: C16H19N3O2

Molecular Weight: 285.35

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC(C)n1ccnc1/C=C/C(=O)/C=C/c1cc(C)on1

Standard InChI:  InChI=1S/C16H19N3O2/c1-4-12(2)19-10-9-17-16(19)8-7-15(20)6-5-14-11-13(3)21-18-14/h5-12H,4H2,1-3H3/b6-5+,8-7+

Standard InChI Key:  JFPKKNKUTRYVKH-BSWSSELBSA-N

Molfile:  

     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
   13.5654  -18.0215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0503  -17.3541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7147  -16.6004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1997  -15.9330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8641  -15.1793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8943  -16.5142    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4290  -13.7272    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.1740  -14.5119    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3490  -14.5119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0941  -13.7272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7615  -13.2423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7615  -12.4173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9009  -18.7752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7079  -18.9467    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7941  -19.7672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0405  -20.1028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4884  -19.4897    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6679  -19.5759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1830  -18.9085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3625  -18.9947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3324  -20.3296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  3  6  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
  7 11  1  0
 11 12  1  0
  5  9  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 13 17  1  0
 18 19  1  0
 19 20  1  0
 18 21  1  0
 17 18  1  0
  1 13  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4211719

    ---

Associated Targets(Human)

PWR-1E (93 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LNCaP (8286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 285.35Molecular Weight (Monoisotopic): 285.1477AlogP: 3.45#Rotatable Bonds: 6
Polar Surface Area: 60.92Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.00CX LogP: 3.25CX LogD: 3.23
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.76Np Likeness Score: -0.98

References

1. Zhang X, Guo S, Chen C, Perez GR, Zhang C, Patanapongpibul M, Subrahmanyam N, Wang R, Keith J, Chen G, Dong Y, Zhang Q, Zhong Q, Zheng S, Wang G, Chen QH..  (2017)  Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.,  137  [PMID:28601720] [10.1016/j.ejmech.2017.05.062]

Source